Recent news

January 2010

Dengue vaccine enters human trials
Australian company Acuvax has announced that its U.S. subsidiary has begun Phase 1 study of an experimental dengue vaccine at the St Louis University Center for Vaccine Development.

 

Sign up for the GHTC newsletter Follow us

Home | Contact us | Privacy policy | Copyright policy

© 2009–2012, Global Health Technologies Coalition.